Greystoke, Dr Alastair

Dr Alastair GreystokeLecturer in Medical Oncology

  • Lecturer in Medical Oncology
  • Tel: (0191) 213-8459
  • GMC Code: 4699475
  • Qualifications: MBChB MSc PhD MRCP
  • Special Interests

    Drug development, Lung Cancer, Personalised medicine, Frailty in Cancer

  • Biography

    Dr Greystoke joined Newcastle University and the Northern Centre for Cancer Care in 2014 after 8 years spent at the University of Manchester/ Christie NHS Trust.  He is one of 3 consultants that run the Sir Bobby Robson Early Clinical Trials Centre at the Freeman hospital in Newcastle, and has a special interest in the development of new anti-cancer drugs for patients with thoracic malignancies. In addition, he is the Joint Chief Investigator of the CONCORDE platform (adding in new drugs to radical radiotherapy in NSCLC), Clinical Lead for Cancer for the Yorkshire, Hull and North East England Genomic Laboratory Hub and he leads the Pharmacodynamic Biomarker team at the Northern Institute for Cancer Research, Newcastle University

  • Directorate

    Cancer Services

  • Hospital Base

    NCCC, Freeman Hospital

  • Clinics Provided

    Early Clinical Trials (Thursday AM and Friday AM); Lung Cancer (Wednesday PM)

  • Name of Secretary
    Dawn Barnett and Joseph Hoben
  • Alastair Greystoke 
© Copyright Newcastle upon Tyne Hospitals NHS Foundation Trust 2019 Site by TH_NK